Physician profile
Manbeen Riar
NPI 1740384148
$810.01
in general payments reported to CMS, 2019-2025
11 companies · $14.92 in 2025
The $14.92 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $127 · 2021: $169 · 2022: $13.60 · 2023: $290 · 2024: $70.75 · 2025: $14.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $193.46 | 2020-2023 | Itero Element 5d Plus |
| Dentsply Sirona INC | $132.88 | 2021-2024 | Suresmile, Primescan Connect |
| Zimmer Biomet Holdings, INC. | $124.12 | 2019 | |
| Nobel Biocare USA | $113.90 | 2023 | Nobelactive |
| Kerr Corporation | $113.90 | 2023 | Tf Adaptive |
| Straumann USA LLC | $39.51 | 2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $37.06 | 2020 | |
| Zimvie INC. | $15.50 | 2023 | |
| Philips North America LLC | $14.92 | 2025 | Oral Hygieneother |
| Elevate Oral Care | $13.60 | 2022 | |
| Ultradent Products INC | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manbeen Riar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.